155 results found

Setor hospitalar será marcado por consolidação e investimentos estratégicos em 2018.

A inovação tecnológica na prestação de serviços de saúde já é uma realidade.

A sócia Elysangela Rabelo explica projeto de lei relativo a pesquisas clínicas e acesso a tratamentos experimentais por pacientes que tenham participado dos ensaios clínicos ...

The opportunities for foreign companies or capital in the Brazilian healthcare sector have recently expanded as a result of the provisions of Law 13.097, dated January 19, 2015.

Está disponível a nova versão do edital de contratação de serviços de informatização das Unidades Básicas de Saúde.

Brazilian startup Carecode has launched with a US$4.3 million pre-seed round. The company is developing AI agents to automate the administrative work surrounding medical appointments...

Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.

A CCT (Comissão de Ciência, Tecnologia, Inovação, Comunicação e Informática), do Senado Federal, aprovou o Projeto de Lei (PLS) nº 167/2014, que autoriza o armazenamento eletrônico...

On March 24, 2022, Celltrion Healthcare announced that it had won a bid to the Brazilian Federal Government to supply a biosimilar version of Remsima® (infliximab), along with bids to 12 Brazilian states.

O Supremo Tribunal Federal ("STF") decidiu, em 15 de agosto de 2018, que o Ministério Público possui legitimidade .

Until now, the healthcare industry was one of the few sectors of the Brazilian economy that was not open to foreign investments.

Law 13,097 of 2015, which resulted from the conversion into law of Provisional Measure 656 of 2014, amended Section 23 of the National Healthcare System Law of 1990 to allow foreign investment in the Brazilian healthcare sector.

Com os dados do sistema, será possível gerar informações sobre próteses e stents implantados, técnicas cirúrgicas utilizadas, perfil dos pacientes e serviços de saúde envolvidos.

The National Health Surveillance Agency (ANVISA) recently rejected a request for a Certificate of Good Manufacturing Practices from Brazil's largest pharmaceutical company-EMS.

The Brazilian National Agency for Sanitary Surveillance (ANVISA) published in July 17, 2018, Resolution RDC 203/2018, which establishes the criteria and procedures for the importation, under exceptional circumstances ...

Em 3 de janeiro de 2022 foi publicada a Lei 14.289 que dispõe sobre o sigilo acerca da condição de pessoas com infecção pelos vírus da HIV, HBV, HCV, hanseníase e com tuberculose.

The Brazilian National Health Surveillance Authority (Anvisa) signed a cooperation project with the Republic of El Salvador through the local regulatory agency for medicine...